ALLISON PRABHAKAR: Open Payments
NPI 1558483834 · NEWTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$660 in 33 payments from 18 companies in 2025. Trend: 2023 $140 · 2024 $267 · 2025 $660
Food & beverage: $546Education: $114
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $126 |
| Novartis Pharmaceuticals Corporation | 5 | $100 |
| Eisai Inc. | 3 | $56 |
| E.R. Squibb & Sons, L.L.C. | 3 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $40 |
| Astellas Pharma US Inc | 2 | $36 |
| PFIZER INC. | 2 | $32 |
| Daiichi Sankyo Inc. | 2 | $32 |
| Genentech USA, Inc. | 1 | $22 |
| TAIHO ONCOLOGY, INC. | 1 | $20 |
Products named: ERLEADA, Lenvima, KISQALI, Nubeqa, OPDUALAG, Vyloy, RYBREVANT, Fabhalta.
Industry payments across PA — which companies pay providers there.
